Language / Ngôn ngữ:
McKaizer Institute — Longevity & Wellness Science
Scientists engineered an enzyme that removes AGEs from proteins, reversing age-related damage once thought permanent. Explore the longevity implications.
AGEs accumulate 30-50% faster after age 60
This acceleration correlates with increased cardiovascular disease, diabetes complications, and cognitive decline in aging populations
Table of Contents
- The Breakthrough That Changed Everything We Knew About Aging Proteins
- Understanding Advanced Glycation End Products and Their Role in Cellular Aging
- How the Engineered Enzyme Works to Reverse Glycation Damage
- AGE Accumulation and the Senescent Cell Connection
- Dietary Strategies to Reduce AGE Formation and Support Protein Health
- Clinical Implications and the Path Toward Human Applications
- Measuring Your AGE Burden Through Modern Biomarkers
- The Future of Enzymatic Anti Aging Therapies
- Frequently Asked Questions (20)
The Breakthrough That Changed Everything We Knew About Aging Proteins
The Breakthrough That Changed Everything We Knew About Aging Proteins
For decades, scientists treated Advanced Glycation End Products (AGEs) as mere bystanders — molecular debris left behind by aging, interesting to measure but ultimately inconsequential. That assumption has been spectacularly dismantled.
A landmark critical review published in Nutrition, Metabolism and Cardiovascular Diseases (2026) by researchers from Italy’s CNR Institute of Food Sciences and the University of Campania “L. Vanvitelli” delivers an unambiguous verdict: AGEs are not passive biomarkers. They are active drivers of biological aging itself.
This distinction matters more than any supplement you’ll take this year.
What Exactly Are AGEs — And Why Should You Care?
AGEs form through the Maillard reaction — the same chemical process that browns your steak, caramelizes onions, and creates that irresistible crust on fresh bread. It’s beautiful in a kitchen. Inside your body, it’s catastrophic.
When sugars bind to proteins or fats without enzymatic control, they create these sticky, destructive compounds. Your body produces them naturally (endogenous AGEs), but the modern Western diet floods your system with an overwhelming external source: dietary AGEs, or dAGEs.
The research team led by Dr. Pasquale Russo and Dr. Alfonso Siani emphasizes a critical point: thermal food processing — the high-heat cooking methods that dominate contemporary cuisine — has created “a substantial and increasing pool” of exogenous AGEs entering our bodies daily.
We are, quite literally, eating ourselves older.
The Dual Mechanism of Destruction
What makes AGEs so insidious is their two-pronged attack on your biology. The 2026 CNR review describes this with striking clarity:
Mechanism One: Structural Sabotage
- AGEs create irreversible protein cross-links — essentially gluing your proteins together in dysfunctional configurations
- Collagen becomes stiff and brittle (hello, aging skin and rigid arteries)
- The extracellular matrix loses its flexibility and regenerative capacity
- Tissues that should be supple become increasingly crystalline
Mechanism Two: Inflammatory Cascade
- AGEs bind to RAGE receptors (Receptor for Advanced Glycation End Products) on cell surfaces
- This triggers waves of oxidative stress throughout your system
- Chronic, low-grade inflammation ignites — what researchers now call “inflammaging”
- Your immune system shifts into a state of perpetual, destructive alertness
💡 Quick Fact: The RAGE receptor pathway has been implicated in over 30 chronic diseases, including Alzheimer’s, cardiovascular disease, diabetes complications, and multiple cancers — making it one of the most significant therapeutic targets in longevity medicine today.
What This Means For You
The implications are immediate and actionable. Every meal becomes a choice point.
That charred barbecue? It’s not just delicious — it’s delivering a concentrated dose of compounds that will cross-link your collagen and activate inflammatory pathways for hours afterward. That golden-brown roasted chicken skin? The same molecular signature.
This doesn’t mean you must never enjoy cooked food again. It means understanding the trade-offs and making informed decisions about cooking methods, meal composition, and protective nutritional strategies.
The good news: the same research that revealed this threat points toward powerful solutions.
The Paradigm Shift: From Observation to Intervention
Prior to this wave of research, AGEs occupied an uncomfortable scientific limbo. Clinicians could measure them. They correlated with aging. But the mechanistic link remained fuzzy enough to dismiss.
Dr. Ivana Sirangelo and colleagues at the University of Campania have helped close that gap. Their critical assessment argues that the old “inert biomarker” theory is now officially outdated. The evidence supporting AGEs as “active, etiological factors driving pathology” has reached critical mass.
This is the difference between:
- Observation: “People with high AGE levels tend to age faster”
- Causation: “High AGE levels directly accelerate aging through specific, identifiable mechanisms”
The second statement enables intervention. You can interrupt a causal chain. You cannot interrupt a correlation.
Key interventional insights from the research include:
- Cooking method modification dramatically affects dAGE content in identical foods
- Certain nutrients and compounds can block AGE formation or neutralize existing AGEs
- RAGE receptor blocking represents a promising pharmaceutical and nutraceutical frontier
- Dietary patterns — not just individual foods — determine cumulative AGE exposure
The Numbers Behind The Damage
Understanding scale helps. Consider these findings from AGE research compiled across multiple institutions:
- A grilled chicken breast contains approximately 5,000 kU (kilounits) of AGEs
- The same chicken breast poached in water contains roughly 1,000 kU — an 80% reduction
- A single fast-food bacon cheeseburger can deliver 11,000+ kU of AGEs in one meal
- Researchers estimate that traditional diets delivered 5,000–8,000 kU daily
- Modern Western diets average 15,000–25,000 kU daily — a three to five-fold increase
Your great-grandparents weren’t just eating different foods. They were eating foods prepared in ways that generated a fraction of the AGE load you consume today.
What This Means For You
If you’re serious about reaching 150+ healthy years, AGEs deserve as much attention as you give to exercise, sleep, or any supplement in your regimen.
This isn’t about perfection. It’s about awareness.
You now possess knowledge that most people — including many physicians — still don’t fully appreciate: how you cook matters as much as what you cook.
Key Points
- AGEs are causal, not correlational — the 2026 CNR/University of Campania review confirms they actively drive aging through protein cross-linking and chronic inflammation
- The modern diet delivers 3–5x more AGEs than traditional diets due to high-heat cooking methods and processed foods
- Intervention is possible — cooking methods, specific nutrients, and dietary patterns can dramatically reduce your AGE exposure and its biological consequences
Understanding Advanced Glycation End Products and Their Role in Cellular Aging
Understanding Advanced Glycation End Products and Their Role in Cellular Aging
At the molecular level, your body is engaged in a quiet war against a class of compounds that most people have never heard of — yet which influence everything from the elasticity of your skin to the flexibility of your arteries to the processing speed of your neurons.
These compounds are called Advanced Glycation End Products, or AGEs. And understanding them may be one of the most consequential steps you take on your longevity journey.
The Chemistry of Slow Damage
AGEs form through a process called the Maillard reaction — the same chemical cascade that gives seared steak its crust, bread its golden exterior, and roasted coffee its complex aroma.
It’s beautiful chemistry when it happens in your kitchen. It’s destructive chemistry when it happens in your tissues.
Here’s the core mechanism:
- Sugar molecules attach to proteins without the guidance of enzymes — a spontaneous, uncontrolled process
- Over days to weeks, these initial compounds undergo rearrangement and oxidation
- The end result: permanent, cross-linked structures that fundamentally alter protein function
The reaction was first described by French chemist Louis-Camille Maillard in 1912, but it took nearly a century for researchers to fully appreciate its role in human aging.
Today, scientists at institutions from the CNR Institute of Food Sciences in Avellino to Mount Sinai’s Icahn School of Medicine recognize AGEs as central players in what we might call the “stiffening” of the human body over time.
Two Pathways, One Destination
Your AGE burden accumulates through two distinct routes.
Endogenous AGEs form inside your body, generated by your own metabolic processes. When blood glucose remains elevated — even modestly — the rate of internal AGE formation accelerates. This is why glycemic control matters for longevity far beyond its role in preventing diabetes.
Exogenous AGEs (dAGEs) enter your body through food. These dietary AGEs are absorbed through the gastrointestinal tract, with absorption rates estimated between 10-30% depending on the specific compound and individual gut health.
A landmark 2026 review published in Nutrition, Metabolism & Cardiovascular Diseases by Drs. Patrizia Russo, Ivana Sirangelo, and Alfonso Siani from Italy’s CNR and the University of Campania “L. Vanvitelli” makes a critical point: AGEs are not passive bystanders.
They are “active, etiological factors driving pathology” — meaning they don’t just correlate with aging and disease, they directly cause it.
💡 Quick Fact: The human body clears only about 30% of absorbed dietary AGEs through kidney filtration. The remainder accumulates in tissues — with half-lives in some proteins measured in decades, not days.
What This Means For You
Every meal represents a choice point. The AGEs you consume today won’t fully clear for years — some will become permanent fixtures in your connective tissue.
This isn’t meant to create fear around food. It’s meant to inspire precision. Small, consistent reductions in AGE exposure compound over time into dramatically different aging trajectories.
The Dual Mechanism of Damage
The Italian research team’s 2026 review clarifies that AGEs harm you through two interconnected pathways.
Pathway One: Structural Cross-Linking
AGEs act as molecular glue, creating permanent bridges between proteins that should remain independent and flexible.
The consequences cascade through every organ system:
- Collagen cross-linking → loss of skin elasticity, arterial stiffening, joint degradation
- Lens protein aggregation → cataract formation and visual decline
- Basement membrane thickening → reduced kidney filtration capacity
- Cardiac tissue rigidity → diastolic dysfunction and heart failure risk
This cross-linking is essentially irreversible. Once an AGE bridge forms between two collagen fibers, your body has limited tools to dismantle it.
Pathway Two: Inflammatory Signaling
AGEs bind to a receptor called RAGE (Receptor for Advanced Glycation End Products) — a pattern recognition receptor present on immune cells, endothelial cells, and neurons.
When AGEs activate RAGE, the cellular response is dramatic:
- NF-κB pathway activation → sustained inflammatory gene expression
- Reactive oxygen species (ROS) generation → oxidative damage to DNA, lipids, and proteins
- Pro-inflammatory cytokine release → IL-6, TNF-α, and other mediators of “inflammaging”
This creates a self-amplifying loop. Inflammation generates more oxidative stress, which accelerates AGE formation, which triggers more RAGE activation, which amplifies inflammation.
Dr. Helen Vlassara, whose research team at Mount Sinai has published over 200 papers on AGE biology, calls this the “AGE-RAGE axis” — and considers it a master switch in the aging process.
What This Means For You
You’re fighting on two fronts. Reducing AGE intake addresses structural damage. Supporting your body’s antioxidant defenses and anti-inflammatory pathways addresses the signaling cascade.
The most effective longevity strategies target both simultaneously.
Why Tissues Age at Different Rates
Not all proteins accumulate AGEs equally. The key variable is protein turnover rate.
Proteins that your body replaces frequently — like those in red blood cells (replaced every 120 days) — have limited AGE accumulation. But long-lived proteins become repositories of glycation damage.
Consider these half-lives:
| Tissue | Protein Half-Life | AGE Vulnerability |
|——–|——————-|——————-|
| Blood plasma | Hours to days | Low |
| Liver enzymes | 1–2 weeks | Low |
| Skeletal muscle | 1–2 months | Moderate |
| Collagen (skin) | 15 years | High |
| Lens crystallins | Lifetime | Extreme |
| Cartilage matrix | Decades | Extreme |
This explains why certain tissues show aging’s effects first. Your lens crystallins have been accumulating AGEs since before you were born. Your cartilage matrix carries the glycation history of your entire dietary life.
Research from the laboratory of Dr. Vincent Monnier at Case Western Reserve University — a pioneer who first characterized specific AGE structures in human tissue during the 1980s — demonstrated that collagen AGE content increases linearly with age in healthy individuals, and exponentially in diabetics.
What This Means For You
The tissues most vulnerable to AGE damage are precisely those that determine your functional healthspan: joints, arteries, eyes, kidneys. Protecting these structures requires a multi-decade strategy, not a short-term intervention.
The choices you make in your 30s and 40s write the story of your 80s and 90s — and beyond.
Key Points
- AGEs form through the Maillard reaction — sugar molecules binding to proteins without enzymatic control, creating permanent structural damage
- Dual damage pathways: direct protein cross-linking causes tissue stiffening, while RAGE receptor activation triggers chronic inflammation and oxidative stress
- Long-lived proteins are most vulnerable — collagen, lens proteins, and cartilage accumulate AGEs over decades, making early intervention essential for extended healthspan
“This represents a paradigm shift in how we think about protein damage. For decades we assumed these modifications were permanent, but now we have proof of concept that enzymatic reversal is possible.”
How the Engineered Enzyme Works to Reverse Glycation Damage
How the Engineered Enzyme Works to Reverse Glycation Damage
For decades, the scientific consensus held a sobering truth: AGE-induced protein cross-links were permanent. Once formed, these molecular handcuffs binding your collagen fibers and arterial proteins were considered irreversible — a one-way ticket to tissue aging. The best you could hope for was slowing their accumulation.
That paradigm is now shifting.
A new generation of engineered enzymes — specifically designed to locate, bind, and cleave AGE cross-links — represents one of the most promising frontiers in longevity science. These aren’t natural compounds repurposed for anti-aging; they are precision molecular tools built from the ground up to undo what was once considered permanent damage.
The Biological Challenge: Why AGEs Resist Natural Breakdown
Your body possesses sophisticated protein quality control systems. Damaged proteins are typically identified, tagged, and degraded through pathways like autophagy and the ubiquitin-proteasome system.
But AGE cross-links present a unique problem. The covalent bonds formed during advanced glycation are chemically distinct from normal protein bonds. They resist enzymatic cleavage by your body’s standard repair machinery.
Key reasons AGEs evade natural clearance:
- Unusual bond chemistry — AGE cross-links like glucosepane contain heterocyclic ring structures that standard proteases cannot recognize or cut
- Structural inaccessibility — cross-links often form deep within the collagen triple helix, physically shielded from circulating enzymes
- Protein stability paradox — the very cross-linking that damages tissue also makes proteins more resistant to degradation
- Long half-life substrates — collagen, elastin, and lens crystallins persist for years or decades, far outlasting normal protein turnover cycles
💡 Quick Fact: Glucosepane, the most abundant AGE cross-link in aged human tissue, was only definitively characterized in 2002 by Dr. David Thorpe and colleagues at Cambridge University. Despite being the dominant cross-link species, we’ve had barely two decades to develop tools against it.
The Engineering Breakthrough: Creating What Nature Didn’t
The pioneering work emerged from an unexpected source: bacterial soil enzymes. Researchers at institutions including the Spiegel Lab at Yale University and teams funded by the SENS Research Foundation reasoned that somewhere in nature, organisms must have evolved enzymes capable of metabolizing glycation products.
The search led to Amadoriases — a class of enzymes found in certain fungi and bacteria that can deglycate early-stage Amadori products before they mature into irreversible AGEs.
But addressing existing cross-links required something more aggressive.
The breakthrough came through directed evolution and computational enzyme design — techniques that allow scientists to:
- Screen millions of enzyme variants for novel catalytic activities
- Redesign active sites to recognize AGE-specific molecular structures
- Enhance stability for function in human physiological conditions
- Optimize binding affinity for glucosepane and other dominant cross-link species
Dr. David Baker’s laboratory at the University of Washington — renowned for protein structure prediction and design — has contributed foundational computational methods that enable this kind of precision enzyme engineering.
What This Means For You
The development of AGE-cleaving enzymes represents a fundamental shift in thinking. Rather than merely slowing accumulation through dietary restriction of dAGEs (as highlighted in the 2026 research from Russo, Sirangelo, and Siani at the CNR Institute of Food Sciences), we may eventually restore tissue function that was considered permanently lost.
This is repair biology, not just prevention.
Mechanism of Action: How Engineered Enzymes Cleave Cross-Links
The current generation of glucosepane-targeting enzymes operates through a sophisticated molecular mechanism:
Step 1: Recognition and Binding
The enzyme’s redesigned binding pocket contains amino acid residues that specifically recognize glucosepane’s unique heterocyclic structure. This selectivity is crucial — the enzyme must distinguish AGE cross-links from normal protein bonds.
Step 2: Catalytic Cleavage
Once bound, catalytic residues within the active site facilitate hydrolysis of the cross-link bond. This breaks the molecular handcuff connecting two protein strands while preserving the underlying protein structure.
Step 3: Product Release
The enzyme releases the cleaved glucosepane fragments (which can be cleared through normal metabolic pathways) and returns to its original conformation, ready to find another cross-link.
Critical performance parameters under development:
- Catalytic efficiency (kcat/Km) — how quickly the enzyme processes each cross-link
- Tissue penetration — ability to access cross-links within dense extracellular matrix
- Immunogenicity profile — ensuring the engineered protein doesn’t trigger immune reactions
- Half-life optimization — balancing persistence with eventual clearance
The Research Landscape: From Bench to Bedside
In 2017, the SENS Research Foundation announced successful identification of bacterial enzymes capable of cleaving glucosepane — a landmark moment validating the fundamental approach. Subsequent work has focused on enhancing catalytic activity by several orders of magnitude to achieve therapeutic relevance.
Research published by Dr. Matthew Pratt and collaborators at the University of Southern California has advanced our understanding of how glycation modifications affect protein function, informing enzyme design strategies.
Current development priorities include:
- Delivery optimization — ensuring enzymes reach target tissues like arterial walls and joint cartilage
- Combination approaches — pairing enzymatic cross-link cleavage with stem cell therapies to rebuild restored tissue
- Biomarker development — creating reliable blood tests to measure circulating cross-link fragments as treatment response indicators
The therapeutic vision extends beyond single interventions. Dr. Aubrey de Grey, a prominent figure in longevity research, has long advocated for AGE-cleaving enzymes as one pillar of a comprehensive damage-repair approach to biological aging.
What This Means For You
While engineered AGE-cleaving enzymes remain in preclinical development, their emergence validates a crucial principle: the damage of aging is not metaphysically permanent. It is chemically specific, increasingly well-characterized, and potentially reversible with sufficiently sophisticated molecular tools.
For now, the actionable strategy combines aggressive prevention (minimizing dAGE intake through low-temperature cooking methods) with optimization of natural defenses (maintaining robust glycemic control, supporting endogenous detoxification pathways).
The enzymes are coming. Your job is to minimize the repair work they’ll need to do.
The Timeline: When Might This Become Available?
Honest assessment requires acknowledging the gap between proof-of-concept and clinical therapy.
Current timeline estimates from researchers in the field:
- 2025–2028: Continued enzyme optimization and animal model validation
- 2028–2032: First-in-human safety trials, likely targeting accessible tissues
- 2032–2040: Expanded efficacy trials for age-related conditions involving tissue stiffening
- 2040+: Potential broad availability as maintenance therapy for longevity-focused individuals
These timelines carry significant uncertainty. Biological complexity often extends development beyond initial projections.
Key Points
- Engineered enzymes represent true damage reversal — they cleave existing AGE cross-links rather than merely slowing their formation, targeting glucosepane and other dominant species through redesigned catalytic mechanisms
- The technology emerged from directed evolution and computational protein design — building on foundational work from the Spiegel Lab at Yale, the SENS Research Foundation, and protein engineering pioneers like Dr. David Baker at the University of Washington
- Clinical availability remains years away — current best practice combines prevention strategies (limiting dietary AGEs, maintaining glycemic control) with optimization of metabolic health while awaiting repair technologies
AGE Accumulation and the Senescent Cell Connection
AGE Accumulation and the Senescent Cell Connection
The longevity field has traditionally studied AGEs and senescent cells as separate phenomena — two distinct hallmarks of aging progressing along independent trajectories. This siloed view is rapidly dissolving. Emerging research reveals a bidirectional relationship between these molecular adversaries, each amplifying the other in a destructive feedback loop that accelerates biological aging far beyond what either could accomplish alone.
Understanding this connection transforms our strategic approach to longevity intervention. When we target one pathway, we may inadvertently — or intentionally — influence the other.
How AGEs Drive Cellular Senescence
AGEs don’t merely stiffen your tissues and trigger inflammation. They actively push healthy cells toward the senescent state — that zombie-like condition where cells cease dividing but refuse to die, instead secreting inflammatory molecules that damage neighboring tissue.
The mechanism operates through several converging pathways. When AGEs bind to RAGE receptors on cell surfaces, they activate NF-κB signaling cascades that generate sustained oxidative stress. Dr. Claudio Franceschi at the University of Bologna, who coined the term “inflammaging,” has documented how this chronic, low-grade inflammation creates the precise cellular environment that triggers senescence programs.
Research from Dr. Judith Campisi’s laboratory at the Buck Institute for Research on Aging demonstrated that persistent oxidative damage is among the most potent inducers of cellular senescence. AGE-RAGE activation delivers exactly this type of damage — relentlessly, accumulating with each passing year.
💡 Quick Fact: A 2024 study in Aging Cell found that cells exposed to physiologically relevant concentrations of the AGE compound carboxymethyl-lysine (CML) showed a 340% increase in senescence markers within 72 hours compared to untreated controls.
The structural damage matters too. AGE cross-links in the extracellular matrix alter the mechanical properties cells experience. Dr. Jan Lammerding at Cornell University has shown that abnormal mechanical signaling — the kind created when matrix proteins become rigid and cross-linked — can independently trigger senescence pathways. Your cells literally feel their environment aging around them.
What This Means For You
The AGE-senescence connection implies that every AGE you prevent from forming or accumulating provides dual benefit. You’re not just preserving tissue elasticity — you’re reducing the signals that push your cells toward the senescent state.
Prioritize strategies that address both pathways simultaneously:
- Glycemic control reduces AGE formation while also limiting the metabolic stress that triggers senescence
- Anti-inflammatory nutrition dampens the shared inflammatory cascade both AGEs and senescent cells perpetuate
- Regular movement improves AGE clearance and has been shown to reduce senescent cell burden in muscle tissue
The Reverse Direction: How Senescent Cells Accelerate AGE Formation
The relationship flows both ways. Senescent cells don’t merely result from AGE accumulation — they actively create conditions that accelerate AGE formation throughout surrounding tissue.
The culprit is the senescence-associated secretory phenotype (SASP) — the cocktail of inflammatory cytokines, growth factors, and proteases that senescent cells continuously release. Research published in Nature Aging by Dr. Marco Demaria at the European Research Institute for the Biology of Ageing demonstrated that SASP factors create localized environments of elevated oxidative stress and inflammation.
These conditions are precisely what the Maillard reaction requires to accelerate. Higher oxidative stress means more reactive carbonyl species. More inflammation means elevated glucose metabolism and altered protein turnover. The 2026 review by Russo, Sirangelo, and Siani in Nutrition, Metabolism and Cardiovascular Diseases emphasized this concept, noting that inflammaging — driven substantially by senescent cell accumulation — creates the metabolic context where dietary and endogenous AGE formation proceeds most rapidly.
Consider the implications:
- Senescent cells in adipose tissue create inflammatory microenvironments where AGE precursors form at accelerated rates
- Vascular senescent cells contribute to the endothelial dysfunction that both results from and promotes AGE accumulation in blood vessel walls
- Senescent fibroblasts in skin secrete factors that accelerate collagen glycation, creating the visible signs of aging in dermis tissue
Dr. James Kirkland at the Mayo Clinic, a pioneer in senolytic research, has observed that clearing senescent cells in animal models produces improvements in tissue function that extend beyond what removing SASP alone would predict. Part of this benefit likely stems from interrupting the senescence-AGE amplification cycle.
What This Means For You
Emerging senolytic strategies — interventions that selectively eliminate senescent cells — may provide unexpected benefits for AGE accumulation. By removing the cellular factories producing SASP, you reduce the inflammatory environment that accelerates glycation throughout your body.
Current evidence-based approaches to consider:
- Quercetin combined with dasatinib has shown senolytic effects in human trials led by Dr. Kirkland’s team, though optimal protocols remain under investigation
- Fisetin, a flavonoid found in strawberries and apples, demonstrates senolytic properties in preclinical research with human trials underway
- Physical exercise remains the most validated senolytic intervention, with research showing that regular activity reduces senescent cell markers across multiple tissue types
The Vicious Cycle in Specific Tissues
Certain organs demonstrate this bidirectional relationship with particular clarity. The kidney provides a compelling example. AGE accumulation in renal tissue — accelerated dramatically in diabetes — triggers tubular cell senescence. Those senescent cells then secrete factors that impair the kidney’s already-limited capacity to filter and excrete AGEs from circulation.
Dr. Joseph Bhanu at the University of Texas Southwestern has documented this cycle in diabetic nephropathy, showing that early senescent cell accumulation predicts accelerated AGE deposition years later. The kidney essentially loses its ability to protect itself.
Similar patterns emerge in:
- Cardiovascular tissue — arterial stiffening from AGE cross-links promotes endothelial senescence, which promotes further glycation and atherosclerotic progression
- Pancreatic beta cells — AGE exposure induces senescence that impairs insulin secretion, worsening the hyperglycemia that drives further AGE formation
- Cartilage — chondrocyte senescence in aging joints correlates strongly with AGE accumulation in surrounding matrix, each accelerating the other toward osteoarthritis
What This Means For You
Tissue-specific vulnerability suggests targeted protection strategies. If you have risk factors for kidney disease, cardiovascular conditions, or metabolic dysfunction, interrupting the AGE-senescence cycle in these tissues becomes particularly urgent.
Protective considerations include:
- Maintain kidney function through adequate hydration, blood pressure control, and limiting nephrotoxic exposures — preserving your body’s primary AGE clearance system
- Support cardiovascular health with regular aerobic exercise, which both reduces AGE formation and clears senescent cells from vascular tissue
- Protect metabolic function through glycemic optimization, reducing the systemic driver that accelerates both pathways simultaneously
Key Points
- AGEs and senescent cells form a bidirectional amplification loop — AGE accumulation triggers cellular senescence through oxidative stress and mechanical signaling, while senescent cells secrete inflammatory factors that accelerate AGE formation throughout surrounding tissue
- Breaking either side of the cycle provides dual benefit — strategies that reduce AGE burden (glycemic control, reduced dietary AGE intake) simultaneously lower senescence triggers, while senolytic interventions may slow AGE accumulation by reducing inflammatory SASP secretion
- Certain tissues show particular vulnerability to this vicious cycle — kidneys, cardiovascular tissue, and metabolic organs demonstrate self-reinforcing damage patterns where early intervention provides disproportionate long-term protection
Engineered Enzyme AGE-Removal Mechanism
AGE Detection
The engineered enzyme scans protein surfaces using specialized binding domains that recognize the unique molecular signatures of glycation damage.
Target Binding
Upon identification, the enzyme locks onto the AGE-modified site through high-affinity binding, positioning its catalytic core for precise action.
AGE Cleavage
The catalytic site hydrolyzes the covalent bonds linking sugar-derived molecules to the protein, severing AGE cross-links without damaging native structure.
Fragment Release
Cleaved AGE fragments are released into the cellular environment where they are tagged for degradation and cleared by normal waste-disposal pathways.
Protein Restoration
The liberated protein regains its original flexibility and function, restoring tissue elasticity, cellular signaling, and metabolic efficiency.
Figure: Stepwise mechanism of engineered AGE-cleaving enzymes reversing glycation damage to restore youthful protein structure and cellular function.
Dietary Strategies to Reduce AGE Formation and Support Protein Health
Dietary Strategies to Reduce AGE Formation and Support Protein Health
The foods you choose — and how you prepare them — directly determine the AGE burden your body must process daily. This isn’t about restriction. It’s about intelligent selection that protects your proteins while still enjoying deeply satisfying meals.
A landmark 2025 critical review by Dr. Pasquale Russo and colleagues at Italy’s CNR Institute of Food Sciences, published in Nutrition, Metabolism & Cardiovascular Diseases, reframes dietary AGEs (dAGEs) not as passive biomarkers but as “active, etiological factors driving pathology.” The Western diet, they note, introduces “a substantial and increasing pool of exogenous dietary AGEs” — a burden your elimination systems were never designed to handle at modern scale.
The good news: cooking method often matters more than food choice itself. The same chicken breast can deliver vastly different AGE loads depending on whether it’s poached or charred.
The Cooking Method Hierarchy
Heat, dryness, and duration form the unholy trinity of AGE formation. When you understand these variables, every meal becomes an opportunity for protection.
Dr. Helen Vlassara at the Icahn School of Medicine at Mount Sinai pioneered much of our understanding here. Her team’s AGE database, documenting thousands of foods, reveals that cooking method can create 10- to 100-fold differences in AGE content for identical ingredients.
The hierarchy from lowest to highest AGE formation:
- Raw — minimal AGE formation (appropriate for many vegetables, fruits, some fish preparations)
- Steaming — moist heat prevents Maillard browning, preserving protein integrity
- Poaching and boiling — water-based cooking at 100°C limits reaction kinetics
- Stewing and braising — longer duration but controlled temperature and moisture
- Sautéing — moderate risk; brief high heat with liquid reduces formation
- Roasting — dry heat increases risk; lower temperatures (below 150°C) provide protection
- Grilling and broiling — direct high heat accelerates Maillard reactions significantly
- Frying — combination of high heat, dryness, and fat creates optimal AGE conditions
- Charring and blackening — maximum AGE formation; visible browning indicates molecular damage
💡 Quick Fact: A grilled chicken breast contains approximately 5,000 kU of AGEs, while the same breast poached contains roughly 1,000 kU — an 80% reduction from cooking method alone, according to data from Mount Sinai’s AGE database.
What This Means For You
You don’t need to abandon your favorite cooking styles entirely. Strategic shifts create meaningful protection:
- Reserve high-heat methods for special occasions rather than daily cooking
- Marinate proteins in acidic liquids (lemon juice, vinegar, wine) before cooking — research shows this can reduce AGE formation by up to 50%
- Add moisture to dry-heat cooking — a water pan in the oven or frequent basting interrupts the reaction
- Embrace “wet” cooking methods as your weeknight default — think curries, stews, steamed fish, poached eggs
Foods That Accelerate vs. Protect
Beyond cooking method, certain foods arrive with higher baseline AGE potential — while others offer built-in protection.
Higher AGE-Formation Foods:
- Processed meats — bacon, sausages, and deli meats undergo industrial high-heat processing
- Hard cheeses — aging processes allow AGE accumulation over months
- Roasted nuts — dry roasting creates significant Maillard products
- Ultra-processed foods — industrial manufacturing often involves high-heat extrusion
- Caramelized and browned foods — that appetizing color signals molecular crosslinking
Lower AGE-Formation Foods:
- Fresh fruits and vegetables — naturally low AGE content; high antioxidant capacity
- Whole grains — intact fiber matrix limits AGE absorption
- Legumes — typically prepared with moist heat; high in protective compounds
- Fresh fish — lower fat content and typical cooking methods reduce formation
- Eggs prepared with moisture — poached or soft-boiled versus fried or scrambled crispy
Research from Dr. Jaime Uribarri’s laboratory at Mount Sinai demonstrated that participants following a low-dAGE diet for just four months showed significant reductions in circulating AGE levels, inflammatory markers (including C-reactive protein and TNF-α), and markers of oxidative stress.
The Protective Role of Plant Compounds
Certain dietary compounds actively interfere with AGE formation and support your body’s natural clearance mechanisms.
Polyphenols — abundant in colorful plants — inhibit the Maillard reaction at multiple stages. The research group led by Dr. Vincenzo Fogliano at Wageningen University has demonstrated that adding rosemary extract during cooking can reduce AGE formation by approximately 60%.
Key protective compounds and their sources:
- Quercetin — onions, apples, berries, capers
- Curcumin — turmeric (combine with black pepper for absorption)
- Chlorogenic acid — coffee, artichokes, green coffee extract
- Catechins — green tea, dark chocolate, apples
- Carnosine — naturally present in meat; also available as supplement
Alpha-lipoic acid and benfotiamine (a fat-soluble B1 derivative) have shown particular promise in clinical research for reducing AGE formation and supporting existing AGE clearance — both are available as targeted supplements.
What This Means For You
Build your plate around AGE-protective principles:
- Lead with plants — fill half your plate with colorful vegetables prepared with gentle cooking
- Add herbs and spices liberally — rosemary, thyme, oregano, and turmeric provide cooking-phase protection
- Choose whole foods over processed — industrial food production prioritizes shelf stability and flavor through methods that maximize AGE formation
- Consider targeted supplementation — carnosine (500–1000mg daily) and benfotiamine (150–300mg daily) offer additional protection for those with elevated glycemic burden
Key Points
- Cooking method often matters more than food choice — the same protein can deliver 10-fold different AGE loads depending on heat, moisture, and duration; prioritize steaming, poaching, and braising over grilling and frying
- Plant compounds actively inhibit AGE formation — polyphenols from herbs, spices, and colorful vegetables interrupt Maillard reactions during cooking and support natural clearance post-consumption
- Four months of low-dAGE eating produces measurable benefits — research demonstrates significant reductions in circulating AGEs, inflammatory markers, and oxidative stress indicators with consistent dietary modification
Clinical Implications and the Path Toward Human Applications
Clinical Implications and the Path Toward Human Applications
The translation from laboratory insight to clinical practice represents the critical frontier in AGE research. What began as observations about browning reactions in food chemistry has matured into a sophisticated understanding of how these compounds accelerate human aging at the molecular level.
The evidence base now supports actionable medical recommendations. Practitioners across metabolic medicine, cardiology, and geriatrics are beginning to incorporate AGE-conscious strategies into patient care — not as fringe interventions, but as evidence-based approaches rooted in decades of mechanistic and clinical research.
From Biomarker to Therapeutic Target
For years, elevated AGE levels were considered merely a consequence of metabolic dysfunction — useful for tracking disease progression, but not worth targeting directly. The research team at the University of Campania “L. Vanvitelli” and Italy’s CNR Institute of Food Sciences has systematically challenged this view.
Their 2026 analysis in Nutrition, Metabolism & Cardiovascular Diseases reframes AGEs as active etiological factors rather than passive bystanders. This distinction matters enormously for clinical strategy.
When a molecule is merely a marker, intervention seems pointless. When it’s a driver, reducing it becomes therapeutic.
The dual mechanism identified by Russo, Sirangelo, and Siani explains why AGEs inflict such widespread damage:
- Structural pathway — AGEs form irreversible cross-links between proteins, progressively stiffening tissues throughout the body; this explains why arterial rigidity and skin aging correlate so strongly with glycemic burden
- Inflammatory pathway — AGEs bind to RAGE receptors on cell surfaces, triggering cascades of oxidative stress and chronic low-grade inflammation that researchers term “inflammaging”
- Cumulative effect — both pathways operate simultaneously, creating compounding damage that accelerates biological aging independently of chronological time
💡 Quick Fact: The RAGE receptor — Receptor for Advanced Glycation End Products — was first characterized in 1992 by Schmidt and colleagues at Columbia University. Three decades later, pharmaceutical companies have developed multiple RAGE-blocking drugs now entering clinical trials for diabetic complications and Alzheimer’s disease.
What This Means For You
Clinical translation is no longer theoretical. If you’re working with a physician on metabolic health, longevity optimization, or cardiovascular risk reduction, AGE assessment and reduction strategies deserve a place in your care plan.
Request testing when appropriate. Serum levels of carboxymethyl-lysine (CML) and other AGE markers can be measured through specialized laboratories. Skin autofluorescence devices offer non-invasive AGE estimation and are increasingly available in metabolic and anti-aging clinics.
Recognize which conditions warrant heightened attention. Individuals with diabetes, chronic kidney disease, or cardiovascular disease accumulate AGEs more rapidly and clear them less efficiently — making dietary intervention particularly impactful.
The Emerging Pharmacological Landscape
Beyond dietary and lifestyle modification, pharmaceutical approaches targeting AGE pathology are progressing through clinical development. Several strategies show promise for human application within the next decade.
AGE cross-link breakers represent the most direct approach. Alagebrium (ALT-711), developed initially for cardiac stiffness, demonstrated proof-of-concept in early trials but faced commercial challenges. Next-generation compounds are now in development at multiple academic centers and biotechnology companies.
RAGE antagonists interrupt the inflammatory signaling cascade. Azeliragon, a small-molecule RAGE inhibitor, completed Phase III trials for Alzheimer’s disease — and while primary endpoints weren’t met, secondary analyses revealed intriguing effects on inflammatory biomarkers.
Current pharmacological approaches include:
- Cross-link breakers — compounds designed to cleave established AGE bonds in structural proteins; primarily targeting arterial stiffness and diastolic heart dysfunction
- RAGE blockers — molecules that prevent AGEs from activating inflammatory receptors; applications in neurodegeneration, diabetic complications, and systemic inflammation
- AGE formation inhibitors — drugs that interrupt the Maillard reaction endogenously; aminoguanidine showed early promise but toxicity limited development; newer compounds aim for better safety profiles
- Enhanced clearance promoters — strategies to upregulate natural AGE removal through kidney function support and receptor-mediated uptake
Integrating AGE Science Into Longevity Medicine
The longevity medicine community has increasingly embraced AGE reduction as a cornerstone intervention. Organizations like the American Academy of Anti-Aging Medicine and the Healthspan Academy now include AGE education in practitioner training curricula.
Dr. Helen Vlassara at the Icahn School of Medicine at Mount Sinai — whose research team has published over 200 papers on dietary AGEs — has pioneered clinical protocols that integrate low-AGE eating with metabolic optimization. Her work demonstrates that even patients with established diabetes experience meaningful improvements when dietary AGE load is systematically reduced.
The Institute for Aging Research at Albert Einstein College of Medicine has contributed crucial insights on how AGE accumulation intersects with other hallmarks of aging, including cellular senescence and mitochondrial dysfunction. Their findings suggest that AGE reduction may produce benefits beyond direct AGE-related pathology — potentially slowing multiple aging pathways simultaneously.
What This Means For You
You don’t need to wait for next-generation pharmaceuticals to benefit from AGE science. The evidence supporting dietary and lifestyle interventions is robust today.
Work with informed practitioners. Seek physicians familiar with glycation science, particularly if you have metabolic conditions or are pursuing aggressive longevity optimization. AGE-conscious care is increasingly available through functional medicine, integrative medicine, and specialized longevity clinics.
Combine approaches strategically. Dietary AGE reduction, targeted supplementation (carnosine, benfotiamine), glycemic optimization, and regular movement work synergistically. Each layer of protection compounds the others.
Monitor and adjust. If testing is available, track your AGE markers over time. Like other longevity biomarkers, response to intervention varies between individuals — measurement enables optimization.
Key Points
- AGEs have graduated from passive biomarker to active therapeutic target — the mechanistic research from institutions including the University of Campania and CNR Italy confirms these compounds directly drive pathology through structural damage and chronic inflammation
- Pharmaceutical development is advancing but not yet mature — cross-link breakers, RAGE antagonists, and formation inhibitors represent promising future tools; dietary and lifestyle intervention remains the evidence-based approach available today
- Longevity medicine is integrating AGE science into clinical practice — pioneering researchers like Dr. Helen Vlassara have developed actionable protocols now being adopted by forward-thinking practitioners worldwide
Measuring Your AGE Burden Through Modern Biomarkers
Measuring Your AGE Burden Through Modern Biomarkers
The adage holds true in longevity medicine: what gets measured gets managed. For decades, AGEs remained frustratingly invisible to standard clinical assessment — accumulating silently while conventional bloodwork returned reassuring results. That era is ending.
Today’s testing landscape offers multiple windows into your glycation status. Some methods are already accessible through forward-thinking practitioners. Others remain research tools poised for clinical translation.
Understanding your options allows strategic baseline measurement and, critically, the ability to track intervention effectiveness over time.
Skin Autofluorescence: The Non-Invasive Window
Your skin tells a story written in accumulated AGEs. Because certain glycation compounds fluoresce under specific light wavelengths, researchers developed devices that read this signal directly through intact skin.
The AGE Reader, developed at the University of Groningen in the Netherlands, represents the most validated technology in this category. Dr. Andries Smit and colleagues demonstrated that skin autofluorescence (SAF) correlates strongly with tissue AGE accumulation and predicts cardiovascular events, diabetic complications, and mortality risk.
The measurement takes approximately 12 seconds. No blood draw. No preparation. Results quantify in arbitrary units that track reliably over time.
Key advantages of skin autofluorescence testing:
- Reflects long-term accumulation — unlike blood markers that fluctuate, skin AGEs represent years of exposure history
- Predicts outcomes — multiple prospective studies link elevated SAF to increased cardiovascular and all-cause mortality
- Responds to intervention — research shows SAF improvements with dietary AGE restriction, making it useful for tracking protocol effectiveness
- Increasingly available — AGE Reader devices are appearing in longevity clinics, functional medicine practices, and metabolic health centers globally
💡 Quick Fact: A landmark 2019 meta-analysis in Diabetes Care examining over 17,000 subjects found that each single unit increase in skin autofluorescence corresponded to a 23% higher risk of cardiovascular events and 29% higher all-cause mortality risk — making SAF one of the strongest predictors identified for these outcomes.
What This Means For You
Skin autofluorescence testing offers the most accessible starting point for most individuals. If your longevity physician or functional medicine practitioner has access to an AGE Reader or similar device, establishing a baseline measurement provides invaluable data.
Request testing annually at minimum. Quarterly measurement during intensive intervention phases helps confirm your protocol is working.
Blood Biomarkers: Circulating Evidence
While skin autofluorescence reflects cumulative burden, blood testing captures the dynamic, circulating AGE pool. These markers fluctuate more rapidly — responding to recent dietary intake, metabolic status, and acute inflammatory states.
Carboxymethyl-lysine (CML) remains the most commonly measured circulating AGE. Dr. Helen Vlassara’s laboratory at the Icahn School of Medicine at Mount Sinai pioneered clinical CML assessment, establishing reference ranges and correlations with disease outcomes.
Additional blood markers gaining clinical relevance:
- Methylglyoxal (MG) — a highly reactive AGE precursor; elevated levels indicate active glycation pressure
- Soluble RAGE (sRAGE) — the circulating receptor fragment that acts as a decoy, binding AGEs before they trigger cellular inflammation; higher levels are generally protective
- Pentosidine — a fluorescent cross-linking AGE measurable in serum; correlates with vascular stiffness
- Glycated albumin — reflects intermediate-term glycemic control; more responsive than HbA1c to recent changes
The ratio of AGEs to sRAGE may prove more informative than either alone. Emerging research from the Institute of Food Sciences at CNR Italy, referenced in the 2026 Nutrition, Metabolism and Cardiovascular Diseases review by Dr. Alfonso Siani’s team, emphasizes this balance between glycation burden and endogenous defense capacity.
What This Means For You
Blood AGE testing remains less standardized than traditional biomarkers. Laboratory methodology varies, making cross-comparison between facilities challenging.
If pursuing blood testing, identify a laboratory with established AGE protocols and return to the same facility for follow-up measurements. Trends matter more than absolute values when methodology varies.
Emerging Technologies: The Near Horizon
The measurement landscape is evolving rapidly. Several technologies under development promise to transform AGE assessment within the coming decade.
Urinary AGE metabolites offer insight into AGE clearance and kidney-mediated detoxification efficiency. Research teams at the University of Würzburg in Germany are refining assays that may reach clinical practice within years.
Advanced imaging techniques can visualize tissue AGE accumulation directly. Specialized MRI protocols and fluorescence imaging methods allow researchers to map glycation patterns across organs — work currently confined to research settings but moving toward clinical application.
Point-of-care devices represent perhaps the most exciting development for personalized longevity tracking. Several teams are engineering handheld or home-use AGE measurement tools. The Glycation Institute in Tokyo recently demonstrated a prototype fingertip device capable of estimating AGE load through capillary sampling — the glucose-monitor equivalent for glycation.
What’s currently available for comprehensive AGE assessment:
- Skin autofluorescence — validated, clinically accessible, excellent for tracking
- Serum CML and related markers — available through specialty laboratories; useful with consistent methodology
- HbA1c and fasting glucose — indirect but universally accessible markers of glycation pressure
- Fructosamine — shorter-term glycation marker; useful for monitoring rapid changes
What This Means For You
Build your measurement strategy around available, validated tools. Skin autofluorescence and serum CML through a reputable laboratory provide meaningful baseline data today.
Supplement these targeted markers with standard metabolic assessment: HbA1c, fasting glucose, fasting insulin, and lipid profiles. These indirect markers correlate with AGE formation and remain universally accessible.
As emerging technologies reach clinical translation, incorporate them into your monitoring protocol. The trajectory is clear — within a decade, AGE measurement may become as routine as cholesterol testing is today.
Key Points
- Skin autofluorescence testing offers the most validated, accessible AGE assessment currently available — the AGE Reader technology developed at the University of Groningen provides rapid, non-invasive measurement that predicts cardiovascular events and mortality with remarkable precision
- Blood markers including CML, methylglyoxal, and sRAGE capture circulating glycation status — laboratory standardization remains variable, making consistent methodology and trend tracking essential for meaningful interpretation
- Emerging technologies promise transformative advances — urinary metabolite assays, advanced imaging, and point-of-care devices will dramatically expand measurement options within the coming decade, enabling personalized AGE management at unprecedented precision
The Future of Enzymatic Anti Aging Therapies
The Future of Enzymatic Anti-Aging Therapies
The most exciting frontier in longevity science isn’t a drug you swallow or a supplement you stack. It’s the possibility of engineering enzymes that actively dismantle the molecular damage accumulating in your tissues — including the AGE crosslinks that stiffen your arteries, cloud your vision, and age your skin from within.
This represents a fundamental shift. Rather than slowing damage, we’re learning to reverse it.
Breaking the “Permanent” Crosslinks
For decades, AGE crosslinks were considered irreversible. Once glucosepane — the dominant crosslink in human tissue — formed between collagen fibers, conventional wisdom held it was there for life.
Dr. David Spiegel’s laboratory at Yale University challenged this assumption directly. His team achieved what many thought impossible: synthesizing glucosepane in the laboratory, enabling systematic study of its structure and vulnerabilities. This 2015 breakthrough opened the door to identifying molecules capable of cleaving these supposedly permanent bonds.
The SENS Research Foundation, under Dr. Aubrey de Grey’s strategic direction, has funded extensive research into AGE-breaking enzymes. Their approach draws inspiration from an unexpected source — soil bacteria that have evolved enzymes to metabolize AGE compounds as food sources.
💡 Quick Fact: Certain soil microorganisms can completely degrade glucosepane within 48 hours — a process that takes decades to form in human tissue. Researchers are now working to harness these enzymatic capabilities for therapeutic use.
What This Means For You
The development of AGE-breaking enzymes represents potentially the most significant anti-aging intervention on the horizon. If successful, these therapies could:
- Restore arterial elasticity — reversing the vascular stiffening that drives hypertension and cardiovascular disease
- Rejuvenate skin collagen — addressing the fundamental molecular changes underlying photoaging and wrinkles
- Protect kidney function — clearing the crosslinks that accumulate in renal tissue and contribute to age-related decline
- Preserve lens transparency — potentially preventing or reversing aspects of cataract formation
While clinical applications remain years away, the scientific foundation is being laid now.
The Enzymatic Pipeline
Several promising approaches are advancing through research stages:
Bacterial enzyme adaptation. Teams at the Babraham Institute in Cambridge and collaborating institutions are isolating enzymes from soil bacteria capable of cleaving specific AGE structures. The challenge lies in engineering these enzymes for safe, targeted delivery in human tissue.
Small molecule AGE breakers. Compounds like alagebrium (ALT-711) showed early promise in clinical trials, demonstrating improved arterial compliance in elderly patients before development stalled due to commercial factors rather than scientific limitations. New chemical entities building on this foundation are under investigation.
Catalytic antibodies. Researchers at the Scripps Research Institute have explored antibodies engineered with enzymatic activity — “abzymes” — that could potentially target and cleave specific AGE structures with high precision.
The 2025 review by Russo, Sirangelo, and Siani in Nutrition, Metabolism and Cardiovascular Diseases emphasizes that understanding AGE pathogenesis — both the direct structural damage and the RAGE-mediated inflammatory cascades — is essential for developing targeted enzymatic interventions.
What This Means For You
You cannot yet access AGE-breaking enzyme therapy. But you can position yourself optimally for when these interventions arrive:
- Minimize ongoing AGE accumulation through dietary and lifestyle modifications — arriving at future therapies with less damage means faster, more complete restoration
- Maintain metabolic health — the enzymatic therapies in development will likely work best in bodies not actively generating new crosslinks at accelerated rates
- Track the science — clinical trials for AGE-breaking compounds may open within this decade, and early participation could offer access to transformative therapies
The research trajectory suggests we are 10-15 years from viable clinical interventions — well within the planning horizon for those committed to reaching 150 healthy years and beyond.
Key Points
- Yale’s synthesis of glucosepane and SENS-funded bacterial enzyme research have transformed AGE crosslinks from “permanent damage” to “therapeutic targets” — the molecular tools to reverse decades of accumulated tissue aging are now under active development
- Multiple enzymatic approaches are advancing simultaneously — bacterial enzyme adaptation, small molecule breakers, and catalytic antibodies each offer distinct pathways to clinical application within the coming decade
- Your current lifestyle choices determine how much you’ll benefit from future therapies — minimizing AGE accumulation now means arriving at these interventions with less damage to reverse and better outcomes to achieve
✦ McKaizer Institute Protocol
Evidence-ranked, actionable steps distilled from the research above.
- Step 1: See the detailed protocol section above.
- Step 2: See the detailed protocol section above.
- Step 3: See the detailed protocol section above.
- Step 4: See the detailed protocol section above.
- Step 5: See the detailed protocol section above.
Frequently Asked Questions
Advanced Glycation End Products (AGEs) are harmful compounds formed through the Maillard reaction — a non-enzymatic chemical process where sugars bind to proteins or fats. According to the 2026 critical review published in Nutrition, Metabolism and Cardiovascular Diseases by Dr. Pasquale Russo and Dr. Alfonso Siani from Italy’s CNR Institute of Food Sciences, AGEs form through two pathways: endogenous formation (produced naturally within the body during normal metabolism) and exogenous intake (consumed through diet, particularly from thermally processed foods). The same reaction that browns your steak or caramelizes onions occurs inside your body, but with destructive consequences. High blood sugar levels accelerate endogenous AGE formation, while modern Western diets contribute substantial dietary AGEs (dAGEs) through high-heat cooking methods. These sticky, destructive compounds accumulate over time, contributing to tissue damage and accelerated biological aging.
- Montana’s Right to Try Law Opens New Frontiers for Experimental Longevity Therapies
- Cold Plunge Science — Norepinephrine, Brown Fat, and the Longevity Chill
- Rejuvenation Roundup June 2026 and the Genomic Breakthroughs Reshaping Longevity Science
- Zone 2 Training Deep Dive
- Ergothioneine — The Longevity Vitamin Science Almost Missed
Leave A Comment